Skip to main content
Advanced Technical IVT

Methylergonovine

Pronunciation: meth-il-ER-goh-noh-veen

An ergot alkaloid uterotonic agent used to treat postpartum hemorrhage, contraindicated with hypertension.

Full Definition

Methylergonovine (Methergine) is an ergot alkaloid that causes sustained uterine contractions and vasoconstriction, used to treat postpartum hemorrhage when first-line agents are ineffective. Unlike oxytocin, it causes tetanic uterine contractions and significant vasoconstriction, making it particularly effective for uterine atony. However, its vasoconstrictive properties make it absolutely contraindicated in hypertensive disorders of pregnancy, including preeclampsia, due to risk of stroke, coronary artery spasm, and severe hypertension. The medication can also cause coronary artery spasm in healthy patients and should be used with caution in cardiac patients.

Usage

Usage note: Absolutely contraindicated in hypertensive disorders; verify blood pressure before administration.

In Context

  • "Methylergonovine was contraindicated due to the patient's history of preeclampsia." — Contraindication documentation
  • "The obstetrician requested methylergonovine 0.2 mg IM after confirming normal blood pressure." — Medication order verification

Also known as

Methergine methylergometrine

Don't confuse with

carboprost ergotamine oxytocin

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON